Merino-Cacho, Laura
Barroso-Gomila, Orhi
Pozo-Rodríguez, Mónica
Muratore, Veronica
Guinea-Pérez, Claudia
Serrano, Álvaro
Pérez, Coralia
Cano-López, Sandra
Urcullu, Ainhoa
Azkargorta, Mikel
Iloro, Ibon
Galdeano, Carles
Juárez-Jiménez, Jordi
Mayor, Ugo
Elortza, Felix
Barrio, Rosa
Sutherland, James D.
Funding for this research was provided by:
Ministerio de Universidades (FPU20/05282)
HORIZON EUROPE Marie Sklodowska-Curie Actions (765445-EU, UbiCODE Program)
HORIZON EUROPE Marie Sklodowska-Curie Actions (765445-EU, UbiCODE Program)
HORIZON EUROPE Marie Sklodowska-Curie Actions (765445-EU, UbiCODE Program)
Ministerio de Ciencia e Innovación (PRE2022-104553)
Ministerio de Ciencia e Innovación (PRE2018-086230)
Ministerio de Ciencia e Innovación (PRE2021-099359)
Ministerio de Ciencia e Innovación (PREP2023-000294)
Cooperation for Science & Technology COST Action (ProteoCure CA20113)
Cooperation for Science & Technology COST Action (ProteoCure CA20113)
Cooperation for Science & Technology COST Action (ProteoCure CA20113)
Cooperation for Science & Technology COST Action (ProteoCure CA20113)
Computational Biology Drug Design Consolidated Research Group, Generalitat de Catalunya (2021SGR00671)
Computational Biology Drug Design Consolidated Research Group, Generalitat de Catalunya (2021SGR00671)
Ministerio de Ciencia, Innovación y Universidades (CNS2022-135307)
Ministerio de Ciencia, Innovación y Universidades (PID2020-117333GB-I00)
Ministerio de Ciencia, Innovación y Universidades (PID2023-147399NB-I00, PID2020-114178GB-I00, CEX2021-001136-S, CEX2021-001202-M)
Ministerio de Ciencia, Innovación y Universidades (PID2023-147399NB-I00, PID2020-114178GB-I00, CEX2021-001136-S, CEX2021-001202-M)
European Union NextGeneration EU/PRTR
Red Española de Supercomputación (BCV-2021-3-0006, BCV-2021-2-0005)
Diputación Foral de Bizkaia (6/12/TT/2023 /00001)
Diputación Foral de Bizkaia (6/12/TT/2023 /00001)
Article History
Received: 25 October 2024
Accepted: 8 February 2025
First Online: 19 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: C.G. is co-founder and Drug Discovery Scientific Advisor of Oniria Therapeutics. The other authors declare that they have no competing interests.